Evidence map›Paper›PMID 26325102›Full record

ArticleBritish journal of cancer2015

International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data.

J Cohen, L Pivodic, G Miccinesi, B D Onwuteaka-Philipsen, W A Naylor, D M Wilson, M Loucka, A Csikos, K Pardon, L Van den Block and 8 more

Open access · hybridAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 5 pooled it
23.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 5 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 10 countries.

J CohenDepartment of Family Medicine & Chronic Care, End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Laarbeeklaan 103, 1090 Brussels, Belgium.
L PivodicDepartment of Family Medicine & Chronic Care, End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Laarbeeklaan 103, 1090 Brussels, Belgium.
G MiccinesiISPO Cancer Prevention and Research Institute, Clinical Epidemiology Unit, Via Oblate 2, Pal 28/A, 50142 Florence, Italy.
B D Onwuteaka-PhilipsenDepartment of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.
W A NaylorHospice Waikato, 334 Cobham Drive, Hillcrest, Hamilton 3216, New Zealand.
D M WilsonFaculty of Nursing, University of Alberta, 11405 87 Avenue, Edmonton, Alberta T6G 1C9, Canada.
M LouckaCenter for Palliative Care, Michelska 1/7, Prague 140 00, Czech Republic.
A CsikosUniversity of Pécs Medical School, 48-as tér 1, 7622 Pécs, Hungary.
K PardonDepartment of Family Medicine & Chronic Care, End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Laarbeeklaan 103, 1090 Brussels, Belgium.
L Van den BlockDepartment of Family Medicine & Chronic Care, End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Laarbeeklaan 103, 1090 Brussels, Belgium.
M Ruiz-RamosInformation and Evaluation Service, Regional Ministry of Health in Andalusia, Av. Innovación, s/n - Edificio Arenas 1, 41071 Seville, Spain.
M Cardenas-TuranzasDepartment of General Internal Medicine, MD Anderson Cancer Center, The University of Texas, Houston, 515 Holcombe Blvd, Houston, TX 77030, USA.
Y RheeDepartment of Health Science, Dongduk Women's University, 23-1 Hawolgok-dong, Seongbuk-gu, Seoul, South Korea.
R AubryFrench National Observatory on End-of-Life Care, 35 Rue du Plateau, 75952 Paris CEDEX 19, France.
K HuntFaculty of Health Sciences, University of Southampton, 104 Burgess Road, Southampton SO17 1BJ, Hampshire, UK.
J TenoCambia Palliative Care Center of Excellence, University of Washington Division of Geriatric Medicine, Box 359765, 401 Broadway, Suite 5123.11 Seattle, WA 98122, USA.
D HouttekierDepartment of Family Medicine & Chronic Care, End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Laarbeeklaan 103, 1090 Brussels, Belgium.
L DeliensDepartment of Family Medicine & Chronic Care, End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Laarbeeklaan 103, 1090 Brussels, Belgium.
Ghent University · BEVrije Universiteit Brussel · BEDongduk Women's University · KREMGO Institute for Health and Care Research · NLGhent University Hospital · BEMinistry of Health · ESOffice National des Forêts · FRPiedmont Reference Center for Epidemiology and Cancer Prevention · ITThe University of Texas MD Anderson Cancer Center · USUniversity of Alberta · CAUniversity of Pecs · HUUniversity of Southampton · GBUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhere people die can influence a number of indicators of the quality of dying. We aimed to describe the place of death of people with cancer and its associations with clinical, socio-demographic and healthcare supply characteristics in 14 countries.

methodsCross-sectional study using death certificate data for all deaths from cancer (ICD-10 codes C00-C97) in 2008 in Belgium, Canada, Czech Republic, England, France, Hungary, Italy, Mexico, the Netherlands, New Zealand, South Korea, Spain (2010), USA (2007) and Wales (N=1,355,910). Multivariable logistic regression analyses evaluated factors associated with home death within countries and differences across countries.

resultsBetween 12% (South Korea) and 57% (Mexico) of cancer deaths occurred at home; between 26% (Netherlands, New Zealand) and 87% (South Korea) occurred in hospital. The large between-country differences in home or hospital deaths were partly explained by differences in availability of hospital- and long-term care beds and general practitioners. Haematologic rather than solid cancer (odds ratios (ORs) 1.29-3.17) and being married rather than divorced (ORs 1.17-2.54) were most consistently associated with home death across countries.

conclusionsA large country variation in the place of death can partly be explained by countries' healthcare resources. Country-specific choices regarding the organisation of end-of-life cancer care likely explain an additional part. These findings indicate the further challenge to evaluate how different specific policies can influence place of death patterns.

Indexed as

AdolescentAdultAgedAged, 80 and overCause of DeathChildChild, PreschoolCross-Sectional StudiesDeath CertificatesFemaleHospitalsHumansInfantInfant, NewbornLong-Term CareMale

Identifiers

PMID26325102
PMCPMC4815784
OpenAlexW2145762305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.